These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21328237)

  • 1. [The lazy eye - contemporary strategies of amblyopia treatment].
    Sturm V
    Praxis (Bern 1994); 2011 Feb; 100(4):229-35. PubMed ID: 21328237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of amblyopia: current practice and emerging trends.
    Papageorgiou E; Asproudis I; Maconachie G; Tsironi EE; Gottlob I
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1061-1078. PubMed ID: 30706134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.
    Repka MX; Kraker RT; Holmes JM; Summers AI; Glaser SR; Barnhardt CN; Tien DR;
    JAMA Ophthalmol; 2014 Jul; 132(7):799-805. PubMed ID: 24789375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children.
    Menon V; Shailesh G; Sharma P; Saxena R
    J AAPOS; 2008 Oct; 12(5):493-7. PubMed ID: 18534880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of penalization methods in moderate to mild amblyopia.
    Tejedor J; Ogallar C
    Am J Ophthalmol; 2008 Mar; 145(3):562-9. PubMed ID: 18207121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years.
    ; Repka MX; Kraker RT; Beck RW; Holmes JM; Cotter SA; Birch EE; Astle WF; Chandler DL; Felius J; Arnold RW; Tien DR; Glaser SR
    Arch Ophthalmol; 2008 Aug; 126(8):1039-44. PubMed ID: 18695096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of treatment of amblyopia in children aged 7 to 17 years.
    Scheiman MM; Hertle RW; Beck RW; Edwards AR; Birch E; Cotter SA; Crouch ER; Cruz OA; Davitt BV; Donahue S; Holmes JM; Lyon DW; Repka MX; Sala NA; Silbert DI; Suh DW; Tamkins SM;
    Arch Ophthalmol; 2005 Apr; 123(4):437-47. PubMed ID: 15824215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia.
    Simons K; Stein L; Sener EC; Vitale S; Guyton DL
    Ophthalmology; 1997 Dec; 104(12):2143-55. PubMed ID: 9400777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and treatment of amblyopia.
    Bradfield YS
    Am Fam Physician; 2013 Mar; 87(5):348-52. PubMed ID: 23547551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amblyopia characterization, treatment, and prophylaxis.
    Simons K
    Surv Ophthalmol; 2005; 50(2):123-66. PubMed ID: 15749306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential bias in amblyopia treatment study.
    Lempert P
    Arch Ophthalmol; 2009 Mar; 127(3):348; author reply 349. PubMed ID: 19273812
    [No Abstract]   [Full Text] [Related]  

  • 12. Amblyopia in children aged 7 to 17 years.
    Phillips CI
    Arch Ophthalmol; 2006 Nov; 124(11):1668; author reply 1668-9. PubMed ID: 17102030
    [No Abstract]   [Full Text] [Related]  

  • 13. Amblyopia.
    Holmes JM; Clarke MP
    Lancet; 2006 Apr; 367(9519):1343-51. PubMed ID: 16631913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance and patching and atropine amblyopia treatments.
    Wang J
    Vision Res; 2015 Sep; 114():31-40. PubMed ID: 25743080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors.
    Pediatric Eye Disease Investigator Group
    Ophthalmology; 2003 Aug; 110(8):1632-7; discussion 1637-8. PubMed ID: 12917184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amblyopia. Part 2: Precautionary measures and therapy].
    Haase W
    Ophthalmologe; 2003 Feb; 100(2):160-72, quiz 173-4. PubMed ID: 12589462
    [No Abstract]   [Full Text] [Related]  

  • 17. The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study.
    Pediatric Eye Disease Investigator Group
    Am J Ophthalmol; 2003 Oct; 136(4):630-9. PubMed ID: 14516802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial.
    Scheiman MM; Hertle RW; Kraker RT; Beck RW; Birch EE; Felius J; Holmes JM; Kundart J; Morrison DG; Repka MX; Tamkins SM;
    Arch Ophthalmol; 2008 Dec; 126(12):1634-42. PubMed ID: 19064841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children.
    Repka MX; Wallace DK; Beck RW; Kraker RT; Birch EE; Cotter SA; Donahue S; Everett DF; Hertle RW; Holmes JM; Quinn GE; Scheiman MM; Weakley DR;
    Arch Ophthalmol; 2005 Feb; 123(2):149-57. PubMed ID: 15710809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration and effect of single-dose atropine: paralysis of accommodation in penalization treatment of functional amblyopia.
    Arnold RW; Gionet E; Hickel J; Owen M; Armitage MD
    Binocul Vis Strabismus Q; 2004; 19(2):81-6. PubMed ID: 15180593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.